Skip to main content

Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q2 23

By: Newsfile

Dallas, Texas--(Newsfile Corp. - August 30, 2023) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (NASDAQ: BPTH) for Q2 2023. The full report can be accessed by clicking on the following link: BPTH Q2 23 Report

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

  • Prexigebersen reports positive interim results
  • $1.7M public offering closed in August
  • BP1001-A Phase 1 trials begin

Cannot view this image? Visit: https://images.newsfilecorp.com/files/7294/179135_figure1_550.jpg

Click image above to view full announcement.



About Stonegate

Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies.

Contacts:

Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com

Source: Stonegate, Inc.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/179135

Recent Quotes

View More
Symbol Price Change (%)
AMZN  205.79
+4.64 (2.31%)
AAPL  265.28
+1.40 (0.53%)
AMD  202.50
-0.58 (-0.29%)
BAC  53.35
+0.61 (1.16%)
GOOG  304.73
+1.91 (0.63%)
META  641.07
+1.78 (0.28%)
MSFT  401.38
+4.52 (1.14%)
NVDA  189.24
+4.27 (2.31%)
ORCL  157.05
+3.08 (2.00%)
TSLA  416.03
+5.40 (1.32%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.